Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Felsenstein Medical Research Center, Petah Tikva, Israel.
Transl Psychiatry. 2019 Jan 17;9(1):15. doi: 10.1038/s41398-018-0354-9.
The 22q11.2 deletion is a strong, but insufficient, "first hit" genetic risk factor for schizophrenia (SZ). We attempted to identify "second hits" from the entire genome in a unique multiplex 22q11.2 deletion syndrome (DS) family. Bioinformatic analysis of whole-exome sequencing and comparative-genomic hybridization array identified de novo and inherited, rare and damaging variants, including copy number variations, outside the 22q11.2 region. A specific 22q11.2-haplotype was associated with psychosis. The interaction of the identified "second hits" with the 22q11.2 haploinsufficiency may affect neurodevelopmental processes, including neuron projection, cytoskeleton activity, and histone modification in 22q11.2DS-ralated psychosis. A larger load of variants, involved in neurodevelopment, in combination with additional molecular events that affect sensory perception, olfactory transduction and G-protein-coupled receptor signaling may account for the development of 22q11.2DS-related SZ. Comprehensive analysis of multiplex families is a promising approach to the elucidation of the molecular pathophysiology of 22q11.2DS-related SZ with potential relevance to treatment.
22q11.2 缺失是精神分裂症(SZ)的一个强有力但不充分的“首要打击”遗传风险因素。我们试图在一个独特的多重 22q11.2 缺失综合征(DS)家族中从整个基因组中识别“次要打击”。全外显子组测序和比较基因组杂交阵列的生物信息学分析确定了 22q11.2 区域以外的新发和遗传、稀有和有害变异,包括拷贝数变异。特定的 22q11.2 单倍型与精神病有关。鉴定的“次要打击”与 22q11.2 单倍体不足的相互作用可能会影响神经发育过程,包括 22q11.2DS 相关精神病中的神经元投射、细胞骨架活性和组蛋白修饰。涉及神经发育的更多变异,加上影响感觉感知、嗅觉转导和 G 蛋白偶联受体信号的其他分子事件,可能导致 22q11.2DS 相关 SZ 的发展。对多重家族的综合分析是阐明 22q11.2DS 相关 SZ 的分子病理生理学的一种很有前途的方法,可能对治疗有潜在的意义。